External Oblique Intercostal Plane Block for Laparoscopic Sleeve Gastrectomy

NCT05663658 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-05-26

No results posted yet for this study

Summary

The external oblique intercostal (EOI) plane block is a novel approach upper abdominal wall analgesia. The EOI plane block can provide dermatomal sensory blockade of T6-T10 at the anterior axillary line and T6-T9 at the midline. It may be used for postoperative analgesia in obese patients because it is superficial and rapidly identifiable and performed in the supine position. the aim of this study is to investigate the postoperative analgesic efficacy of external oblique intercostal plane block in obese patients undergoing laparoscopic sleeve gastrectomy.

Researchers will compare the external oblique intercostal plane block group with control group to see if the EOI plane block is effective for postoperative analgesia in patients undergoing sleeve gastrectomy.

Conditions

  • Obesity
  • Analgesia
  • Postoperative Pain

Interventions

OTHER

Intravenous morphine patient control device

24-hour morphine consumption will be recorded

OTHER

External oblique intercostal plane block

External oblique intercostal plane block will be administered before the surgery.

Sponsors & Collaborators

  • Istinye University

    lead OTHER

Principal Investigators

  • Ali Sait Kavakli, M.D. · Istinye University

  • Taylan Sahin, M.D. · Istinye University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-23
Primary Completion
2023-05-01
Completion
2023-05-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05663658 on ClinicalTrials.gov